We hypothesized that downregulating signaling of PI3K/AKT, NFκB, and MMP2/9 can result in increased extracellular proBDNF concentrations leading to cytotoxic effects on lung cancer cells via a mechanism involving p53. The gene discussed is TP53; the disease is lung carcinoma.